ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Aug. 18, 2022 Molecular Partners AG , a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin. | August 18, 2022
Molecular Partners Announces Publication in Nature Biotechnology Detailing Design and Mechanism of Ensovibep DARPin Antiviral for SARS-CoV-2 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Molecular Partners Announces Participation in Scientific Conferences forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.